Patient-Centered Clinical Outcome Assessments in Clinical Trials: Role for Assessing Treatment Benefit in Angelman Syndrome. Angelman Syndrome Biomarker and Outcome Measurement Consortium (A-BOM). December 2018
Invited Talk
Service Performed By
- Zigler, Christina Kelsey Assistant Professor in Population Health Sciences
Date
- December 2018
Service or Event Name
- Angelman Syndrome Biomarker and Outcome Measurement Consortium (A-BOM)